Published in J Pharmacol Exp Ther on October 07, 2011
Mechanisms and environmental factors that underlying the intensification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced serotonin syndrome in rats. Psychopharmacology (Berl) (2014) 0.79
Characterization of electroencephalographic and biochemical responses at 5-HT promoting drug-induced onset of serotonin syndrome in rats. J Neurochem (2013) 0.78
Subjective reports of the effects of MDMA in a clinical setting. J Psychoactive Drugs (1987) 2.20
Spatiotemporal convergence and divergence in the rat S1 "barrel" cortex. J Comp Neurol (1987) 2.10
Non-linear pharmacokinetics of MDMA ('ecstasy') in humans. Br J Clin Pharmacol (2000) 1.55
Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion: pharmacological and behavioral studies. Neuroscience (1988) 1.54
Effects of alcohol and other drugs on driver performance. Traffic Inj Prev (2004) 1.51
Repeated cocaine modifies the mechanism by which amphetamine releases dopamine. J Neurosci (1997) 1.37
Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy. J Psychopharmacol (2005) 1.29
Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges. Neuroscience (2008) 1.22
MDMA elicits behavioral and neurochemical sensitization in rats. Neuropsychopharmacology (1998) 1.15
Effects of dose and route of administration on pharmacokinetics of (+ or -)-3,4-methylenedioxymethamphetamine in the rat. Drug Metab Dispos (2009) 1.15
Psychostimulant sensitization: differential changes in accumbal shell and core dopamine. Eur J Pharmacol (2000) 1.12
Interaction of norepinephrine with cerebrocortical activity evoked by stimulation of somatosensory afferent pathways in the rat. Exp Neurol (1980) 1.08
Lateralization and functional organization of the locus coeruleus projection to the trigeminal somatosensory pathway in rat. J Comp Neurol (1997) 1.08
Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses. J Pharmacol Exp Ther (2008) 1.04
Modulation of rat cortical area 17 neuronal responses to moving visual stimuli during norepinephrine and serotonin microiontophoresis. Brain Res (1990) 1.04
Mechanism of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated mitochondrial dysfunction in rat liver. Proteomics (2008) 1.03
Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis. J Anal Toxicol (2002) 1.01
Topographic organization and neurochemical identity of dorsal raphe neurons that project to the trigeminal somatosensory pathway in the rat. J Comp Neurol (2001) 0.97
Differences in cutaneous sensory response properties of single somatosensory cortical neurons in awake and halothane anesthetized rats. Brain Res Bull (1981) 0.95
Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine1B agonist. J Pharmacol Exp Ther (1992) 0.93
Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat. Psychopharmacology (Berl) (1999) 0.92
Interaction of serotonin with somatosensory cortical neuronal responses to afferent synaptic inputs and putative neurotransmitters. Brain Res Bull (1986) 0.90
Ecstasy-induced toxicity in rat liver. Liver (2000) 0.90
Low blood alcohol concentrations and driving impairment. A review of experimental studies and international legislation. Int J Legal Med (1994) 0.85
Behavioral, thermal and neurochemical effects of acute and chronic 3,4-methylenedioxymethamphetamine ("Ecstasy") self-administration. Behav Brain Res (2009) 0.85
In vivo pharmacology of MDMA and its enantiomers in rhesus monkeys. Exp Clin Psychopharmacol (2008) 0.83
MDMA (3,4-methylenedioxymethamphetamine)-mediated distortion of somatosensory signal transmission and neurotransmitter efflux in the ventral posterior medial thalamus. J Pharmacol Exp Ther (2008) 0.81
Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys. Neurotoxicol Teratol (1996) 0.81
Acute administration of 3,4-methylenedioxymethamphetamine (MDMA) induces oxidative stress, lipoperoxidation and TNFα-mediated apoptosis in rat liver. Pharmacol Res (2011) 0.80
A matter of focus: monoaminergic modulation of stimulus coding in mammalian sensory networks. Curr Opin Neurobiol (2004) 1.53
Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of corticotropin-releasing factor. Brain Res (1991) 1.46
The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses. Ann N Y Acad Sci (1993) 1.30
Effects of locus coeruleus inactivation on electroencephalographic activity in neocortex and hippocampus. Neuroscience (1993) 1.20
Systemic administration of WIN 55,212-2 increases norepinephrine release in the rat frontal cortex. Brain Res (2005) 1.13
Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice. J Pharmacol Exp Ther (2001) 1.10
Lateralization and functional organization of the locus coeruleus projection to the trigeminal somatosensory pathway in rat. J Comp Neurol (1997) 1.08
Norepinephrine exhibits two distinct profiles of action on sensory cortical neuron responses to excitatory synaptic stimuli. Synapse (2000) 1.08
Interaction of norepinephrine with cerebrocortical activity evoked by stimulation of somatosensory afferent pathways in the rat. Exp Neurol (1980) 1.08
Modulatory actions of norepinephrine in the central nervous system. Fed Proc (1979) 1.03
The distribution of neocortical projection neurons in the locus coeruleus. J Comp Neurol (1983) 0.99
Topographic organization and neurochemical identity of dorsal raphe neurons that project to the trigeminal somatosensory pathway in the rat. J Comp Neurol (2001) 0.97
Differences in cutaneous sensory response properties of single somatosensory cortical neurons in awake and halothane anesthetized rats. Brain Res Bull (1981) 0.95
Activation of the locus ceruleus brain noradrenergic system during stress: circuitry, consequences, and regulation. Adv Pharmacol (1998) 0.95
Topographical distribution of dorsal and median raphe neurons projecting to motor, sensorimotor, and visual cortical areas in the rat. J Comp Neurol (1986) 0.94
Noradrenergic modulation of somatosensory cortical neuronal responses to iontophoretically applied putative neurotransmitters. Exp Neurol (1980) 0.93
Progesterone alters GABA and glutamate responsiveness: a possible mechanism for its anxiolytic action. Brain Res (1987) 0.93
Evidence for widespread afferents to Barrington's nucleus, a brainstem region rich in corticotropin-releasing hormone neurons. Neuroscience (1994) 0.93
Interaction of serotonin with somatosensory cortical neuronal responses to afferent synaptic inputs and putative neurotransmitters. Brain Res Bull (1986) 0.90
Sex steroid effects on extrahypothalamic CNS. II. Progesterone, alone and in combination with estrogen, modulates cerebellar responses to amino acid neurotransmitters. Brain Res (1987) 0.90
Noradrenergic potentiation of excitatory transmitter action in cerebrocortical slices: evidence for mediation by an alpha 1 receptor-linked second messenger pathway. Brain Res (1991) 0.90
Pharmacological comparison of two corticotropin-releasing factor antagonists: in vivo and in vitro studies. J Pharmacol Exp Ther (1994) 0.90
Origin, distribution, and morphology of galaninergic fibers in the rodent trigeminal system. J Comp Neurol (1999) 0.88
Locally applied estrogens potentiate glutamate-evoked excitation of cerebellar Purkinje cells. Brain Res (1988) 0.88
Alpha-receptor-mediated facilitation of somatosensory cortical neuronal responses to excitatory synaptic inputs and iontophoretically applied acetylcholine. Neuropharmacology (1981) 0.88
Projection patterns from the raphe nuclear complex to the ependymal wall of the ventricular system in the rat. J Comp Neurol (1998) 0.87
Norepinephrine enhancement of inhibitory synaptic mechanisms in cerebellum and cerebral cortex: mediation by beta adrenergic receptors. J Pharmacol Exp Ther (1982) 0.86
Noradrenergic potentiation of cerebellar Purkinje cell responses to GABA: evidence for mediation through the beta-adrenoceptor-coupled cyclic AMP system. Brain Res (1989) 0.86
Noradrenergic modulation of cat area 17 neuronal responses to moving visual stimuli. Brain Res (1994) 0.85
Sex steroid effects on extrahypothalamic CNS. I. Estrogen augments neuronal responsiveness to iontophoretically applied glutamate in the cerebellum. Brain Res (1987) 0.84
Noradrenergic enhancement of GABA-induced input resistance changes in layer V regular spiking pyramidal neurons of rat somatosensory cortex. Brain Res (1995) 0.83
MDMA (3,4-methylenedioxymethamphetamine)-mediated distortion of somatosensory signal transmission and neurotransmitter efflux in the ventral posterior medial thalamus. J Pharmacol Exp Ther (2008) 0.81
Effects of systemically and locally applied cocaine on cerebrocortical neuron responsiveness to afferent synaptic inputs and glutamate. Brain Res (1991) 0.81
Locus coeruleus stimulation potentiates Purkinje cell responses to afferent input: the climbing fiber system. Brain Res (1981) 0.80
Locally applied progesterone metabolites alter neuronal responsiveness in the cerebellum. Brain Res Bull (1987) 0.80
Systemically administered cocaine alters stimulus-evoked responses of thalamic somatosensory neurons to perithreshold vibrissae stimulation. Brain Res (1998) 0.80
Modulatory actions of norepinephrine on neural circuits. Adv Exp Med Biol (1991) 0.80
Effects of systemic and local ethanol on responses of rat cerebellar Purkinje neurons to iontophoretically applied gamma-aminobutyric acid. Brain Res (1995) 0.79
Effects of intravenous cocaine administration on cerebellar Purkinje cell activity. Eur J Pharmacol (2000) 0.79
The cerebellar norepinephrine system: inhibition, modulation, and gating. Prog Brain Res (1991) 0.78
Effects of systemic and local ethanol on responses of rat cerebellar Purkinje neurons to iontophoretically applied norepinephrine and gamma-aminobutyric acid. Brain Res (1995) 0.78
Locus coeruleus stimulation potentiates local inhibitory processes in rat cerebellum. Brain Res Bull (1983) 0.78
Modulatory interactions between norepinephrine and taurine, beta-alanine, gamma-aminobutyric acid and muscimol, applied iontophoretically to cerebellar Purkinje cells. Neuropharmacology (1981) 0.78
Comparison of norepinephrine- and benzodiazepine-induced augmentation of Purkinje cell responses to gamma-aminobutyric acid (GABA). J Pharmacol Exp Ther (1984) 0.78
Regulation of nerve growth factor mRNA in the hippocampal formation effects of N-methyl-D-aspartate receptor activation. Exp Neurol (1993) 0.77
Evidence that dopamine-beta-hydroxylase immunoreactive neurons in the lateral reticular nucleus project to the spinal cord in the rat. Anat Rec (2001) 0.76
Selective suppression of excitatory synapses on GABAergic interneurons by norepinephrine in juvenile rat prefrontal cortical microcircuitry. Neuroscience (2013) 0.76
Systemically administered cocaine selectively enhances long-latency responses of rat barrel field cortical neurons to vibrissae stimulation. J Pharmacol Exp Ther (1995) 0.76
Survival of the fittest. J Maxillofac Orthop (1972) 0.75
Electrophysiological actions of VIP in rat somatosensory cortex. Peptides (1992) 0.75
Localization of mu-opioid receptors to locus coeruleus-projecting neurons in the rostral medulla: morphological substrates and synaptic organization. Synapse (1999) 0.75
Image analysis and computer graphics: emerging applications in ethanol research. Alcohol Clin Exp Res (1986) 0.75
Electrophysiological assessment of monoamine synaptic function in neuronal circuits of seizure susceptible brains. Life Sci (1986) 0.75
Simple spike activity of Purkinje cells in the posterior vermis of awake cats during spontaneous saccadic eye movements. Brain Res Bull (1980) 0.75
Systemic and prosthodontic treatment to prevent bone resorption in edentulous patients. J Prosthet Dent (1975) 0.75
Microelectrode implantation technique for use in the awake and unrestrained cat. Physiol Behav (1977) 0.75
Better dentures with flat occlusal surfaces. Dent Dig (1972) 0.75